// App-Quantinova.ai

P13 : Immune Checkpoint Inhibitor Related Auto Immune Demyelinating Polyneuropathy

Researchers

Presenter

  • S. A. Mohammed

Principal Investigators

  • S. Hadigal

  • S. Sutchu

  • A. Saleem

Medical Centers

  • Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, FL, United States

  • Internal Medicine, Veteran Affairs Medical Center, Gainesville, FL, United States

  • Pulmonary Critical Care Medicine, UF - Shands, Gainesville, FL, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

  • Peripheral Nervous System

  • Musculoskeletal

  • Central Nervous System (CNS)

  • Infectious Diseases (ID)

  • Cardiovascular (CVS)

Disease

  • Metastatic Renal Cell Cancer

  • Non Small Cell Lung cancer

  • Coronary Artery Disease

  • Small cell lung cancer

  • Renal cell carcinoma

  • Melanoma

  • Myasthenia gravis

  • Peripheral neuropathy

  • Hypertension

  • Lung Cancer

  • Viral myocarditis

  • Solid malignancies

  • Myositis

  • Stroke

Biomarkers

  • Cytotoxic T-lymphocyte-associated protein 4

  • Programmed cell death protein 1

  • Programmed death-ligand 1

  • White Blood Cell

  • X-Ray Repair Cross Complementing 1

  • Red Blood Cells

Drug/Treatment

  • Ipilimumab

  • Nivolumab

  • Rituximab

  • IVIG

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved